greeksoup/ stock research
Stock research / United States / NVS / Year to 31 December 2021

Novartis AG (NVS) annual results, year to 31 December 2021: revenue USD 42,781 million, from the 20-F

Novartis AG files a 20-F with the SEC once a year, in US dollars. In the year to 31 December 2021 it reported revenue from the sale of goods of USD 42,781 million, down 12.1% on the year before. Its profit attributable to shareholders was USD 24,021 million, up 197.6%, and diluted earnings per share USD 10.63.

Revenue
USD 42,781 million
-12.1% on the year
FY2016FY2021
Operating margin
23.5%
20.9% a year earlier
FY2016FY2021
Net income
USD 24,021 million
+197.6% on the year
FY2016FY2021
Diluted EPS
USD 10.63
+202.0% on the year
FY2016FY2021

this yearthe year beforeIn US dollars as filed. Hover a bar for its figure.

Income statement (profit and loss)

Year toDec 2020 †Dec 2021 †
Revenue from the sale of goods48,65942,781
Cost of sales15,12111,735
Gross profit34,77732,239
Research and development8,9808,641
Selling, general and administrative14,19712,827
Operating profit10,15210,056
Profit before tax9,87824,530
Income tax1,8071,625
Profit for the year8,07124,018
Profit attributable to shareholders8,07224,021
Filing20-F20-F
USD million, from the 20-F on the SEC's EDGAR, linked in the last row, on the IFRS tags the company filed.
Read moreA line the company does not file under the standard tag is left out rather than estimated.
Year toDec 2020 †Dec 2021 †
Diluted EPS3.5210.63
Basic EPS3.5510.71
Filing20-F20-F

USD per ordinary share, as filed.

Cash flow

Year toDec 2020 †Dec 2021 †
Cash from operations13,65015,071
Purchase of property, plant and equipment1,2751,066
Free cash flow12,37514,005
Cash from investing-13,1824,208
Cash from financing-2,208-16,264
Buybacks2,8423,057
Dividends paid6,9877,368
Filing20-F20-F

USD million. Free cash flow is cash from operations less the purchase of property, plant and equipment, arithmetic on the two filed lines.

Balance sheet

Year toDec 2020 †Dec 2021 †
Funded by
Equity attributable to shareholders56,59867,655
Non-controlling interests68.0167
Borrowings, as filed28,53125,523
Lease liabilities2,0051,896
Other liabilities40,57636,554
Total equity and liabilities127,778131,795
Owned
Property, plant and equipment12,26311,545
Goodwill29,99929,595
Other intangible assets36,80934,182
Cash and cash equivalents9,65812,407
Inventories7,1316,666
Other assets31,91837,400
Total assets127,778131,795
Filing20-F20-F

USD million, at each fiscal year end.

Ratios on the filed lines

Year toDec 2020 †Dec 2021 †
Return on year-end equity14.3%35.5%
Effective tax rate18.3%6.6%
Filing20-F20-F

Arithmetic on the filed lines of the same year.

20-F for the year to 31 December 2021, filed 31 January 2024: the filing. The figures are in US dollars as filed.